BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ghosh SK, Weinberg A. Ramping Up Antimicrobial Peptides Against Severe Acute Respiratory Syndrome Coronavirus-2. Front Mol Biosci 2021;8:620806. [PMID: 34235176 DOI: 10.3389/fmolb.2021.620806] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
Number Citing Articles
1 Ciurkiewicz M, Armando F, Schreiner T, de Buhr N, Pilchová V, Krupp-Buzimikic V, Gabriel G, von Köckritz-Blickwede M, Baumgärtner W, Schulz C, Gerhauser I. Ferrets are valuable models for SARS-CoV-2 research. Vet Pathol 2022;:3009858211071012. [PMID: 35001763 DOI: 10.1177/03009858211071012] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
2 White JH. Emerging Roles of Vitamin D-Induced Antimicrobial Peptides in Antiviral Innate Immunity. Nutrients 2022;14:284. [PMID: 35057465 DOI: 10.3390/nu14020284] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
3 Huțanu A, Georgescu AM, Voidăzan S, Andrejkovits AV, Negrea V, Dobreanu M. Low Serum Vitamin D in COVID-19 Patients Is Not Related to Inflammatory Markers and Patients' Outcomes-A Single-Center Experience and a Brief Review of the Literature. Nutrients 2022;14:1998. [PMID: 35631138 DOI: 10.3390/nu14101998] [Reference Citation Analysis]
4 Grant WB, Lordan R. Vitamin D for COVID-19 on Trial: An Update on Prevention and Therapeutic Application. Endocr Pract 2021:S1530-891X(21)01260-X. [PMID: 34648940 DOI: 10.1016/j.eprac.2021.10.001] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Ismailova A, White JH. Vitamin D, infections and immunity. Rev Endocr Metab Disord 2021. [PMID: 34322844 DOI: 10.1007/s11154-021-09679-5] [Cited by in Crossref: 13] [Cited by in F6Publishing: 10] [Article Influence: 13.0] [Reference Citation Analysis]
6 Kongsbak-Wismann M, Al-Jaberi FAH, Schmidt JD, Ghanizada M, Hansen CB, Lopez DV, Woetmann A, Ødum N, Bonefeld CM, Stryhn A, Garred P, Buus S, Geisler C. Normal T and B Cell Responses Against SARS-CoV-2 in a Family With a Non-Functional Vitamin D Receptor: A Case Report. Front Immunol 2021;12:758154. [PMID: 34659264 DOI: 10.3389/fimmu.2021.758154] [Reference Citation Analysis]
7 Li X, Zuo S, Wang B, Zhang K, Wang Y. Antimicrobial Mechanisms and Clinical Application Prospects of Antimicrobial Peptides. Molecules 2022;27:2675. [PMID: 35566025 DOI: 10.3390/molecules27092675] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Ali W, Elsahn A, Ting DSJ, Dua HS, Mohammed I. Host Defence Peptides: A Potent Alternative to Combat Antimicrobial Resistance in the Era of the COVID-19 Pandemic. Antibiotics 2022;11:475. [DOI: 10.3390/antibiotics11040475] [Reference Citation Analysis]
9 Aloul KM, Nielsen JE, Defensor EB, Lin JS, Fortkort JA, Shamloo M, Cirillo JD, Gombart AF, Barron AE. Upregulating Human Cathelicidin Antimicrobial Peptide LL-37 Expression May Prevent Severe COVID-19 Inflammatory Responses and Reduce Microthrombosis. Front Immunol 2022;13:880961. [DOI: 10.3389/fimmu.2022.880961] [Reference Citation Analysis]
10 Zhang L, Ghosh SK, Basavarajappa SC, Chen Y, Shrestha P, Penfield J, Brewer A, Ramakrishnan P, Buck M, Weinberg A. HBD-2 binds SARS-CoV-2 RBD and blocks viral entry: Strategy to combat COVID-19. iScience 2022;25:103856. [PMID: 35128350 DOI: 10.1016/j.isci.2022.103856] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
11 Enayathullah MG, Parekh Y, Banu S, Ram S, Nagaraj R, Kumar BK, Idris MM. Gramicidin S and melittin: potential anti-viral therapeutic peptides to treat SARS-CoV-2 infection. Sci Rep 2022;12:3446. [PMID: 35236909 DOI: 10.1038/s41598-022-07341-x] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]